These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10523129)

  • 1. Update treatment of multidrug-resistant tuberculosis. Introduction, discussion and summary.
    Youngchaiyud P; Iseman MD
    Chemotherapy; 1999; 45 Suppl 2():1-2, 41-5. PubMed ID: 10523129
    [No Abstract]   [Full Text] [Related]  

  • 2. [Usefulness of studies on antitubercular drug resistance].
    Valenzuela P
    Rev Panam Salud Publica; 1997 Jan; 1(1):62-7. PubMed ID: 9162582
    [No Abstract]   [Full Text] [Related]  

  • 3. Bedaquiline.
    Goulooze SC; Cohen AF; Rissmann R
    Br J Clin Pharmacol; 2015 Aug; 80(2):182-4. PubMed ID: 25702772
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoniazid-resistant disseminated Mycobacterium tuberculosis in a Jamaican infant with HIV/AIDS.
    Singh-Minott I; Pierre RB; Olugbuyi O; Dunkley-Thompson J; Haughton D; Christie CD
    West Indian Med J; 2008 Jun; 57(3):298-301. PubMed ID: 19583132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Review article titled, "Rifamycins - Obstacles and opportunities" by Paul A. Aristoff, George A. Garcia, Paul D. Kirchhoff, H.D. Hollis Showalter. Tuberculosis 2010; 90(2):94-118.
    Sayada C
    Tuberculosis (Edinb); 2010 Sep; 90(5):326; author reply 326-7. PubMed ID: 20691638
    [No Abstract]   [Full Text] [Related]  

  • 7. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
    [No Abstract]   [Full Text] [Related]  

  • 8. [Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective].
    Lazareva NB; Khaĭmenova TIu; Khaĭmenov AIa
    Antibiot Khimioter; 2008; 53(5-6):14-20. PubMed ID: 19069177
    [No Abstract]   [Full Text] [Related]  

  • 9. The worldwide epidemic of multidrug-resistant tuberculosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-resistant tuberculosis: what do we do now?
    Telenti A; Iseman M
    Drugs; 2000 Feb; 59(2):171-9. PubMed ID: 10730543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 12. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital-based surveillance for DR-TB: necessary but not sufficient.
    Beavers SF; Holtz TH; Garrett DO
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):5. PubMed ID: 20003688
    [No Abstract]   [Full Text] [Related]  

  • 14. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
    Veen J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis susceptibility--implications for drug development and therapy.
    Snell NJ
    Expert Opin Pharmacother; 2003 Sep; 4(9):1455-60. PubMed ID: 12943474
    [No Abstract]   [Full Text] [Related]  

  • 16. Multidrug resistant tuberculosis: a continuing crisis.
    Burki T
    Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistant plus susceptible tuberculosis: the undiscovered country.
    Ahmad Khan F; Behr M
    J Infect Dis; 2014 Jun; 209(11):1682-4. PubMed ID: 24523512
    [No Abstract]   [Full Text] [Related]  

  • 18. Acquired drug resistance during inadequate therapy in a young child with tuberculosis.
    Garcia-Prats AJ; Willemse M; Seifart HI; Jordaan AM; Werely CJ; Donald PR; Schaaf HS
    Pediatr Infect Dis J; 2014 Aug; 33(8):883-5. PubMed ID: 25222312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
    Tahaoğlu K; Kizkin O; Karagöz T; Tor M; Partal M; Sadoğlu T
    Tuber Lung Dis; 1994 Oct; 75(5):324-8. PubMed ID: 7841424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis
    Patel N; O'Malley T; Zhang YK; Xia Y; Sunde B; Flint L; Korkegian A; Ioerger TR; Sacchettini J; Alley MRK; Parish T
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.